Filtrera efter Last updated date SelectEfterFöreFrom - To Date Slutdatum Denna vecka Den här månaden Förra veckan Förra månaden Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Lämna detta fält tomt Filter Resultat (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Lämna detta fält tomt Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched 25 januari 2022NewsHumanClinical trials Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) 24 januari 2022NewsHumanCOVID-19Vaccines Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 januari 2022NewsVeterinaryMaximum residue limitMedicines International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 januari 2022NewsHumanCOVID-19 COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy 18 januari 2022NewsHumanCOVID-19Vaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022 14 januari 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines EMA welcomes EU Commissioner for Health and Food Safety 13 januari 2022NewsCorporateCOVID-19 Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs 13 januari 2022NewsHumanClinical trials Global regulators discuss path towards regulatory alignment on response to Omicron variant 13 januari 2022NewsHumanCOVID-19Vaccines Preliminary data indicate COVID-19 vaccines remain effective against severe disease and hospitalisation caused by the Omicron variant 11 januari 2022NewsHumanCOVID-19Vaccines 1 … 50 51 52 53 54 Page 54 of 383 55 56 57 58 … 383
Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched 25 januari 2022NewsHumanClinical trials
Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) 24 januari 2022NewsHumanCOVID-19Vaccines
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 januari 2022NewsVeterinaryMaximum residue limitMedicines
International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 januari 2022NewsHumanCOVID-19
COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy 18 januari 2022NewsHumanCOVID-19Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022 14 januari 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines
Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs 13 januari 2022NewsHumanClinical trials
Global regulators discuss path towards regulatory alignment on response to Omicron variant 13 januari 2022NewsHumanCOVID-19Vaccines
Preliminary data indicate COVID-19 vaccines remain effective against severe disease and hospitalisation caused by the Omicron variant 11 januari 2022NewsHumanCOVID-19Vaccines